The Intra-articular Shoulder Injection of Botulinum Toxin A on Stroke Patients with Complex Regional Pain Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To evaluate the short-term clinical effects of intra-articular shoulder injection with botulinum toxin type A (BoNT-A) in acute hemiplegic stroke patients with complex regional pain syndrome type I (CRPS I). Method Fifty patients were assigned at random to receive intra-articular shoulder injection. The treatment groups were divided into two groups: BoNT-A group, 200 IU of BoNT-A and 2 ml of normal saline; triamcinolone acetonide (TA) group, 20 mg of triamcinolone and 2 ml of 2% lidocaine. Uptake ratio of quantitative three phase bone scintigraphy (QTPBS) was calculated by dividing the radioactivity count on the affected side by that on the unaffected side. Shoulder pain was assessed by visual analogue scale (VAS) and neuropathic pain scale (NPS). Range of motion (ROM) of shoulder joint and functional independence measurement (FIM) of upper limb were evaluated. All of them were measured before injection, and 4 weeks after injection. Results After 4 weeks, the uptake ratio of blood pool phase was significantly decreased in hands of BoNT-A group than TA group. VAS, ROM and upper extremity FIM was similarly improved in both groups. Pain intensity and cold pain of NPS were similarly decreased in both groups. Hot pain and dull pain of NPS decreased more significantly decreased in BoNT-A group than TA group. Conclusion In the short-term, intra-articular BoNT-A shoulder injection maybe has the therapeutic effect on acute CRPS I related stroke. And the uptake ratio of blood pool phase of the hand of QTPBS may be useful to assess the therapeutic effect of CRPS after acute stroke.
Abstract
Objective To evaluate the short-term clinical effects of intra-articular shoulder injection with botulinum toxin type A (BoNT-A) in acute hemiplegic stroke patients with complex regional pain syndrome type I (CRPS I). Method Fifty patients were assigned at random to receive intra-articular shoulder injection. The treatment groups were divided into two groups: BoNT-A group, 200 IU of BoNT-A and 2 ml of normal saline; triamcinolone acetonide (TA) group, 20 mg of triamcinolone and 2 ml of 2% lidocaine. Uptake ratio of quantitative three phase bone scintigraphy (QTPBS) was calculated by dividing the radioactivity count on the affected side by that on the unaffected side. Shoulder pain was assessed by visual analogue scale (VAS) and neuropathic pain scale (NPS). Range of motion (ROM) of shoulder joint and functional independence measurement (FIM) of upper limb were evaluated. All of them were measured before injection, and 4 weeks after injection. Results After 4 weeks, the uptake ratio of blood pool phase was significantly decreased in hands of BoNT-A group than TA group. VAS, ROM and upper extremity FIM was similarly improved in both groups. Pain intensity and cold pain of NPS were similarly decreased in both groups. Hot pain and dull pain of NPS decreased more significantly decreased in BoNT-A group than TA group. Conclusion In the short-term, intra-articular BoNT-A shoulder injection maybe has the therapeutic effect on acute CRPS I related stroke. And the uptake ratio of blood pool phase of the hand of QTPBS may be useful to assess the therapeutic effect of CRPS after acute stroke.
참고문헌 (30)
- Holer LE, "Reflex sympathetic dystrophy in the hands; clinical and scintigraphic criteria", Radiology, 152, pp.517~522 (1984)
- Cepeda MS, "Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome: a narrative and systematic review", Clin J Pain, 18, pp.216~233 (2002)
- van der Laan L, "Reflex sympathetic dystrophy. An exaggerated regional inflammatory response?", Hand Clin, 13, pp.373~385 (1997)
- de Mos M, "Current understanding of complex regional pain syndrome", Pain Pract, 9, pp.86~99 (2009)
- McCabe CS, "A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1)", Rheumatology, 42, pp.97~101 (2003)
- Robinson JN, "Efficacy of pamidronate in complex regional pain syndrome type I", Pain Med, 5, pp.276~280 (2004)
- Stannard CF, "Dural puncture during attempted stellate ganglion block", Anaesthesia, 45, pp.952~954 (1990)
- Mense S, "Neurobiological basis for the use of botulinum toxin in pain therapy", J Neurol, 251(Suppl.1), pp.1~7 (2004)
- Stanton-Hicks MD, "An updated interdisciplinary clinical pathway for CRPS: report of an expert panel", Pain Pract, 2, pp.1~16 (2002)
- White S, "Assessment of chronic neuropathic pain and the use of pain tools", Br J Nurs, 13, pp.372~378 (2004)
- Wesseldijk F, "Bogaerts-Taal E, Zijlstra FJ. Increased plasma serotonin in complex regional pain syndrome type 1", Anesth Analg, 106, pp.1862~1867 (2008)
- Schwartzman RJ, "Reflex sympathetic dystrophy and causalgia", Neurol Clin, 10, pp.953~973 (1992)
- Leitha T, "Five phase bone scintigraphy supports the pathophysiological concept of a subclinical inflammatory process in reflex sympathetic dystrophy", QJ Nucl Med, 40, pp.188~193 (1996)
- Wesseldijk F, "Increased plasma glutamate, glycine, and arginine levels in complex regional pain syndrome type I", Acta Anaesthesiol Scand, 52, pp.688~694 (2008)
- Gokkaya NK, "Reflex sympathetic dystrophy in hemiplegia", Int J Rehabil Res, 29, pp.275~279 (2006)
- Kong KH, "A randomized controlled study of botulinum toxin a in the treatment of hemiplegic shoulder pain associated with spasticity", Clin Rehabil, 21, pp.28~35 (2007)
- de Boer KS, "Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin a into the subscapular muscle", J Neurol Neurosurg Psychiatry, 79, pp.581~583 (2008)
- Mahowald ML, "Long term effects of intra-articular botulinum toxin a for refractory joint pain", Neurotox Res, 9, pp.179~188 (2006)
- Singh JA, "Repeat injections of intra-articular botulinum toxin a for the treatment of chronic arthritis joint pain", J Clin Rheumatol, 15, pp.35~38 (2009)
- Ozturk E, "Quantitative three-phase bone scintigraphy in the evaluation of intravenous regional blockade treatment in patients with stage-I reflex sympathetic dystrophy of upper extremity", Ann Nucl Med, 18, pp.653~658 (2004)
- Kozin F, "Bone scintigraphy in the reflex sympathetic dystrophy syndrome", Radiology, 138, pp.437~443 (1981)
- Davidoff G, "Predictive value of the three-phase technetium bone scan in diagnosis of reflex sympathetic dystrophy syndrome", Arch Phys Med Rehabil, 70, pp.135~137 (1989)
- Geurts AC, "Systemic review of aetiology and treatment of post-stroke hand oedema and shoulder-hand syndrome", Scand J Rehabil Med, 32, pp.4~10 (2000)
- Atkins RM, "Quantitative bone scintigraphy in reflex sympathetic dystrophy", Br J Rhematol, 32, pp.41~45 (1993)
- Kozin F, "The reflex sympathetic dystrophy syndrome: II. Roentgenographic and scintigraphic evidence of bilaterally and periarticular accentuation", Am J Med, 60, pp.332~338 (1976)
- Zyluk A, "The usefulness of quantitative evaluation of three- phase scintigraphy in the diagnosis of post-traumatic reflex sympathetic dystrophy", J Hand Surg Br, 24, pp.16~21 (1999)
- Zyluk A, "Quantitative evaluation of three- phase bone scintigraphy before and after the treatment of post-traumatic reflex sympathetic dystrophy", Nucl Med Commun, 20, pp.327~333 (1999)
- 이우련, "뇌졸중 후 복합국소동통증후군에서 삼상골스캔 섭취비의 유용성", Annals of Rehabilitation Medicine, 31(1), pp.41~47 (2007), 대한재활의학회
- Rog DJ, "Validation and reliability of the neuropathic pain scale (NPS) in multiple sclerosis", Clin J Pain, 23, pp.473~481 (2007)
- Kurvers HA, "Reflex sympathetic dystrophy: facts and hypotheses", Vasc Med, 3, pp.207~214 (1998)